Nov. 13, 2007
GENSENSE FOR GENOMICS
The University of British Columbia’s James Hogg iCAPTURE Center for Cardiovascular and Pulmonary Research has chosen InforSense’s GenSense workflow-based analytics platform to support genetic research programs. The center, based at St. Paul’s Hospital in Vancouver, hopes GenSense will aid in analyzing large data sets generated by genotyping.
Thermo Fisher Scientific has acquired NanoDrop Technologies, a leading manufacturer of micro-volume ultraviolet visible instrumentation. The acquisition strengthens Thermo’s portfolio of UV-Vis spectrophotometry instruments, and came just two weeks before CEO Marijn E. Dekkers hinted at more acquisition “opportunities” to come in the wake of a strong Q3.
CRIX International, the Clinical Research Information Exchange, has chosen Northrop Grumman to provide support and security services for the CRIX technology platform. CRIX hopes to offer life sciences organizations with services to make clinical work processes more efficient. Northrop Grumman will handle hosting, security, scaling, credentialing of users, and the help desk for the platform, which is set to be operational in early 2008.
A study published in the Proceedings of the National Academy of Sciences (October 2007) identifying proteins associated with ovarian cancer relied on Invitrogen’s Proto-Array technology to identify proteins present in cancer patients’ blood that may be useful in developing future diagnostic tests. The arrays identified more than 94 candidate biomarkers with enhanced reactivity in cancer patients.